Core Viewpoint - The domestic surgical robot industry is at a critical turning point from "concept validation" to "scale profitability" with the implementation of medical insurance policies and accelerated overseas market expansion [1] Market Size and Growth - The Chinese surgical robot market is projected to grow from 7.2 billion RMB in 2024 to 76.7 billion RMB by 2032, representing a compound annual growth rate (CAGR) of approximately 34% [2][3] - In comparison, the global market is expected to increase from 21.2 billion USD to 75 billion USD during the same period, with a CAGR of about 17%, indicating that China's growth rate significantly outpaces the global average [3] Segment Analysis - Laparoscopic surgical robots will dominate the market, accounting for 58% of the total market size in 2024, with a projected CAGR of about 29% from 2024 to 2032, reaching 32.1 billion RMB by 2032 [6] - The orthopedic surgical robot market follows closely, with a projected CAGR of 41% from 2024 to 2032, reaching 21.3 billion RMB by 2032 [6] Policy Impact - The year 2026 is identified as a pivotal moment for policy implementation, addressing the issue of "who pays" for surgical robots, which has been a barrier to adoption [8][9] - The release of the medical insurance guidelines on January 20, 2026, will clarify the reimbursement framework, significantly easing the entry barriers for surgical robots into hospitals [9] International Expansion - The Chinese surgical robot market currently accounts for about 5% of the global market, indicating substantial overseas market potential [10] - Leading domestic companies are rapidly expanding into international markets, with significant orders and certifications achieved, such as MicroPort's 160 global commercial orders and the CE certifications for various products [10][11] Business Model - The surgical robot industry follows a "razor and blades" business model, where the primary revenue comes from consumables and services rather than just equipment sales [12] - Companies are encouraged to focus on increasing installation base as a key leading indicator for future cash flow, similar to the strategy employed by Intuitive Surgical [12]